Lifetime endogenous estrogen exposure and electrocardiographic frontal T axis changes in postmenopausal women

Maturitas

Volumn 63, Issue 4, 2009, Pages 347-351

  Atsma, Femke ^a   van der Schouw, Yvonne T ^a   Grobbee, Diederick E ^a   Kors, Jan A ^b   Bartelink, Marie Louise E L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Blood pressure; Electrocardiography; Estrogens; Repolarization; Women

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; ESTROGEN ACTIVITY; FEMALE; HEART MUSCLE; HEART PROTECTION; HEART REPOLARIZATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; POSTMENOPAUSE; T WAVE;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; ELECTROCARDIOGRAPHY; ESTROGENS; FEMALE; HEART; HUMANS; LOGISTIC MODELS; MENSTRUAL CYCLE; MIDDLE AGED; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 68149164774     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.06.001     Document Type: Article

References (36)

1. Kannel W.B., Hjortland M.C., McNamara P.M., and Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 85 (1976) 447-452
2. Gordon T., Kannel W.B., Hjortland M.C., and McNamara P.M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 89 (1978) 157-161
3. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., and Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med 316 (1987) 1105-1110
4. Parrish H.M., Carr C.A., Hall D.G., and King T.M. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 99 (1967) 155-162
5. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
6. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study Follow-up (HERS II). JAMA 288 (2002) 49-57
7. Hsia J., Langer R.D., Manson J.E., et al. Conjugated equine estrogens and coronary heart disease: the women's health initiative. Arch Intern Med 166 (2006) 357-365
8. Atsma F., Bartelink M., Grobbee D.E., and Schouw van der Y.T. Postmenopausal status, early menopause and cardiovascular disease: a meta-analysis. Menopause 13 (2006) 265-279
9. Palmer J.R., Rosenberg L., and Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 136 (1992) 408-416
10. La Vecchia C., Decarli A., Franceschi S., Gentile A., Negri E., and Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol 157 (1987) 1108-1112
11. Cooper G.S., Ephross S.A., Weinberg C.R., Baird D.D., Whelan E.A., and Sandler D.P. Menstrual and reproductive risk factors for ischemic heart disease. Epidemiology 10 (1999) 255-259
12. Winkelstein W., Stenchever M.A., and Lilienfield A.M. Occurrence of pregnancy, abortion, and artificial menopause among women with coronary artery disease: a preliminary study. J Chronic Dis 7 (1958) 273-286
13. de Kleijn M.J., van der Schouw Y.T., and van der G.Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas 33 (1999) 7-36
14. Kors J.A., de Bruyne M.C., Hoes A.W., et al. T axis as an indicator of risk of cardiac events in elderly people. Lancet 352 (1998) 601-605
15. Rautaharju P.M., Nelson J.C., Kronmal R.A., et al. Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (The Cardiovascular Health Study). Am J Cardiol 88 (2001) 118-123
16. Pham T.V., and Rosen M.R. Sex, hormones, and repolarization. Cardiovasc Res 53 (2002) 740-751
17. Boker L.K., van Noord P.A., van der Schouw Y.T., et al. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol 17 (2001) 1047-1053
18. de Kleijn M.J., van der Schouw Y.T., Verbeek A.L., Peeters P.H., Banga J.D., and van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 155 (2002) 339-345
19. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13 (2002) 831-838
20. van Bemmel J.H., Kors J.A., and van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med 29 (1990) 346-353
21. Kors J.A., van Herpen G., Sittig A.C., and van Bemmel J.H. Reconstruction of the Frank vectorcardiogram from standard electrocardiographic leads: diagnostic comparison of different methods. Eur Heart J 11 (1990) 1083-1092
22. Alagiakrishnan K., Beitel J.D., Graham M.M., et al. Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization. Am J Cardiol 96 (2005) 639-642
23. Kardys I., Kors J.A., van der Meer I.M., Hofman A., van der Kuip D.A., and Witteman J.C. Spatial QRS-T angle predicts cardiac death in a general population. Eur Heart J 24 (2003) 1357-1364
24. Clavel-Chapelon F., and Dormoy-Mortier N. A validation study on status and age of natural menopause reported in the E3N cohort. Maturitas 29 (1998) 99-103
25. Bean J.A., Leeper J.D., Wallace R.B., Sherman B.M., and Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol 109 (1979) 181-185
26. Must A., Phillips S.M., Naumova E.N., et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?. Am J Epidemiol 155 (2002) 672-679
27. Cooper R., Blell M., Hardy R., et al. Validity of age at menarche self-reported in adulthood. J Epidemiol Commun Health 60 (2006) 993-997
28. Rexrode K.M., Manson J.E., Lee I.M., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 108 (2003) 1688-1693
29. Hanke H., Hanke S., Ickrath O., et al. Estradiol concentrations in premenopausal women with coronary heart disease. Coron Artery Dis 8 (1997) 511-515
30. Ossewaarde M.E., Bots M.L., Verbeek A.L., et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 16 (2005) 556-562
31. Richardson S.J., Senikas V., and Nelson J.F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65 (1987) 1231-1237
32. Burger H.G., Dudley E.C., Robertson D.M., and Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 57 (2002) 257-275
33. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20 (1991) 47-63
34. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., and Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133 (2000) 933-941
35. Grodstein F., Manson J.E., and Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Ann Intern Med 135 (2001) 1-8
36. Grodstein F., Manson J.E., and Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt.) 15 (2006) 35-44